Mostrar el registro sencillo del ítem
| dc.contributor.author | López, Aurelio | |
| dc.contributor.author | Mateos, Maria-Victoria | |
| dc.contributor.author | Oriol, Albert | |
| dc.contributor.author | Valero, Marta | |
| dc.contributor.author | Martínez, Joaquin | |
| dc.contributor.author | Lorenzo, José-Ignacio | |
| dc.contributor.author | Pérez, Montserrat | |
| dc.contributor.author | Martínez, Rafael | |
| dc.contributor.author | de-Paz, Raquel | |
| dc.contributor.author | Granell, Miguel | |
| dc.contributor.author | de-Arriba-de-la-Fuente, Felipe | |
| dc.contributor.author | Blanchard, M-Jesus | |
| dc.contributor.author | Peñalver, Francisco-Javier | |
| dc.contributor.author | Bello, José-Luis | |
| dc.contributor.author | Martin, Maria-Luisa | |
| dc.contributor.author | Bargay, Joan | |
| dc.contributor.author | Blade, Joan | |
| dc.contributor.author | Lahuerta, Juan-Jose | |
| dc.contributor.author | San-Miguel, Jesus-F | |
| dc.contributor.author | de-la-Rubia, Javier | |
| dc.date.accessioned | 2026-10-21T06:14:01Z | |
| dc.date.available | 2026-10-21T06:14:01Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | Lopez A, Mateos MV, Oriol A, Valero M, Martínez J, Lorenzo JI, et al. Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations. Leukemia Research Reports. 2015;4(2):64-9. doi:10.1016/j.lrr.2015.09.002 | |
| dc.identifier.issn | 2213-0489 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/28788 | |
| dc.description.abstract | We report the characteristics of relapse, treatment response, and outcomes of 145 elderly patients with multiple myeloma in first relapse after front-line treatment with VMP or VTP. Reappearance of CRAB symptoms (113 patients) and more aggressive forms of disease (32 patients) were the most common patterns of relapse. After second-line therapy, 75 (51.7%) patients achieved at partial response and 16 (11%) complete response (CR). Overall survival was longer among patients receiving VMP as front-line induction (21.4 vs. 14.4 months, P=0.037), in patients achieving CR (28.3 vs. 14.8 months; P=0.04), and in patients without aggressive relapse (28.6 vs. 7.6 months; P=0.0007). | |
| dc.language.iso | eng | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | * |
| dc.title | Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations. | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 26500850 | |
| dc.relation.publisherversion | https://linkinghub.elsevier.com/retrieve/pii/S2213048915300133 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1016/j.lrr.2015.09.002 | |
| dc.journal.title | Leukemia Research Reports |